Anzeige
Mehr »
Login
Samstag, 28.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Jetzt ist die Zeit, um in unterbewertete Goldaktien mit MEGA-Hebel zu investieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
918 Leser
Artikel bewerten:
(2)

International Business Machines Corp - 1st Quarter Results

International Business Machines Corp - 1st Quarter Results

PR Newswire


IBM RELEASES FIRST QUARTER RESULTS

Double-Digit Software and Consulting Growth Led by Hybrid Cloud Adoption; Strong Profit Generation

ARMONK, N.Y., April 19, 2022 -- IBM (NYSE: IBM) today announced first-quarter 2022 earnings results.

"Demand for hybrid cloud and AI drove growth in both Software and Consulting in the first quarter. Today we're a more focused business and our results reflect the execution of our strategy," said Arvind Krishna, IBM chairman and chief executive officer. "We are off to a solid start for the year, and we now see revenue growth for 2022 at the high end of our model."

First-Quarter Highlights

  • Revenue
    - Revenue of $14.2 billion, up 8 percent, up 11 percent at constant currency (over 5 points from incremental sales to Kyndryl)
    - Software revenue up 12 percent, up 15 percent at constant currency (over 8 points from incremental sales to Kyndryl)
    - Consulting revenue up 13 percent, up 17 percent at constant currency
    - Infrastructure revenue down 2 percent, flat at constant currency (over 8 points from incremental sales to Kyndryl)
    - Hybrid cloud revenue:
    -- First Quarter: $5.0 billion, up 14 percent, up 17 percent at constant currency
    -- Last 12 months: $20.8 billion, up 17 percent
  • Free Cash Flow
    - On a consolidated basis, net cash from operating activities of $3.2 billion; free cash flow of $1.2 billion
FIRST QUARTER 2022 INCOME STATEMENT SUMMARY
Pre-tax
GrossPre-tax Income Net Diluted
RevenueProfitIncomeMarginIncomeEPS
GAAP from
Continuing
Operations
$14.2B$7.3B$0.6B4.4%$0.7B$0.73
Year/Year8%*4%156%2.5Pts64%62%
Operating
(Non-GAAP)
$7.5B$1.5B10.7%$1.3B$1.40
Year/Year4%46%2.8Pts25%25%
* 11% at constant currency

"In the first quarter we continued to strengthen the fundamentals of our business, consistent with our medium-term model," said James Kavanaugh, IBM senior vice president and chief financial officer. "We are a faster growing, more profitable company with a higher-value business mix, a significant recurring revenue base and strong cash generation."

Segment Results for First Quarter

  • Software (includes Hybrid Platform & Solutions, Transaction Processing)- revenues of $5.8 billion, up 12.3 percent, up 15.4 percent at constant currency (over 8 points from incremental sales to Kyndryl):
    - Hybrid Platform & Solutions up 7 percent, up 10 percent at constant currency (about 1.5 points from incremental sales to Kyndryl):
    -- Red Hat up 18 percent, up 21 percent at constant currency
    -- Automation up 3 percent, up 5 percent at constant currency
    -- Data & AI up 2 percent, up 4 percent at constant currency
    -- Security up 5 percent, up 8 percent at constant currency
    - Transaction Processing up 26 percent, up 31 percent at constant currency (about 28 points from incremental sales to Kyndryl)
    - Software segment hybrid cloud revenue up 22 percent, up 25 percent at constant currency
  • Consulting (includes Business Transformation, Technology Consulting and Application Operations)- revenues of $4.8 billion, up 13.3 percent, up 17.4 percent at constant currency:
    - Business Transformation up 15 percent, up 19 percent at constant currency
    - Technology Consulting up 14 percent, up 19 percent at constant currency
    - Application Operations up 10 percent, up 14 percent at constant currency
    - Consulting segment hybrid cloud revenue up 24 percent, up 29 percent at constant currency
  • Infrastructure (includes Hybrid Infrastructure, Infrastructure Support)- revenues of $3.2 billion, down 2.3 percent, up 0.3 percent at constant currency (over 8 points from incremental sales to Kyndryl):
    - Hybrid Infrastructure down 5 percent, down 2 percent at constant currency (over 8 points from incremental sales to Kyndryl)
    -- IBM z Systems down 19 percent, down 18 percent at constant currency
    -- Distributed Infrastructure up 5 percent, up 8 percent at constant currency
    - Infrastructure Support flat, up 4 percent at constant currency (over 8 points from incremental sales to Kyndryl)
    - Infrastructure segment hybrid cloud revenue down 20 percent, down 18 percent at constant currency
  • Financing (includes client and commercial financing)- revenues of $0.2 billion, down 26.2 percent, down 24.5 percent at constant currency

Cash Flow and Balance Sheet
On a consolidated basis, in the first quarter, the company generated net cash from operating activities of $3.2 billion or $1.6 billion excluding IBM Financing receivables. IBM's free cash flow was $1.2 billion, which includes cash impacts from the company's structural actions initiated at the end of 2020.

IBM ended the first quarter with $10.8 billion of cash on hand (which includes marketable securities), up $3.2 billion from year-end 2021. Debt, including IBM Financing debt of $12.2 billion, totaled $54.2 billion, up $2.5 billion since the end of 2021. The company returned $1.5 billion to shareholders in dividends in the first quarter.

Full-Year 2022 Expectations

  • Revenue growth: The company now expects constant currency revenue growth at the high end of the mid-single digit range. The company also expects an additional 3.5 point contribution from incremental sales to Kyndryl. At mid-April 2022 foreign exchange rates, currency is expected to be a three to four point headwind.
  • Free Cash Flow: The company continues to expect $10 billion to $10.5 billion in consolidated free cash flow.

Forward-Looking and Cautionary Statements
Except for the historical information and discussions contained herein, statements contained in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on the company's current assumptions regarding future business and financial performance. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, including, but not limited to, the following: a downturn in economic environment and client spending budgets; a failure of the company's innovation initiatives; damage to the company's reputation; risks from investing in growth opportunities; failure of the company's intellectual property portfolio to prevent competitive offerings and the failure of the company to obtain necessary licenses; the company's ability to successfully manage acquisitions, alliances and dispositions, including integration challenges, failure to achieve objectives, the assumption of liabilities, and higher debt levels; fluctuations in financial results; impact of local legal, economic, political, health and other conditions; the company's failure to meet growth and productivity objectives; ineffective internal controls; the company's use of accounting estimates; impairment of the company's goodwill or amortizable intangible assets; the company's ability to attract and retain key employees and its reliance on critical skills; impacts of relationships with critical suppliers; product quality issues; impacts of business with government clients; reliance on third party distribution channels and ecosystems; cybersecurity and data privacy considerations; adverse effects related to climate change and environmental matters, tax matters; legal proceedings and investigatory risks; the company's pension plans; currency fluctuations and customer financing risks; impact of changes in market liquidity conditions and customer credit risk on receivables; potential failure of the separation of Kyndryl Holdings, Inc. to qualify for tax-free treatment; risk factors related to IBM securities; and other risks, uncertainties and factors discussed in the company's Form 10-Qs, Form 10-K and in the company's other filings with the U.S. Securities and Exchange Commission or in materials incorporated therein by reference. Any forward-looking statement in this release speaks only as of the date on which it is made. Except as required by law, the company assumes no obligation to update or revise any forward-looking statements.

Presentation of Information in this Press Release
On November 3, 2021, IBM completed the separation of Kyndryl. Unless otherwise specified, results are presented on a continuing operations basis.

In an effort to provide investors with additional information regarding the company's results as determined by generally accepted accounting principles (GAAP), the company has also disclosed in this press release the following non-GAAP information, which management believes provides useful information to investors:

IBM results -

  • adjusting for currency (i.e., at constant currency);
  • presenting operating (non-GAAP) earnings per share amounts and related income statement items;
  • consolidated free cash flow;
  • consolidated cash from operating activities excluding IBM Financing receivables;

The rationale for management's use of these non-GAAP measures is included in Exhibit 99.2 in the Form 8-K that includes this press release and is being submitted today to the SEC.

Conference Call and Webcast
IBM's regular quarterly earnings conference call is scheduled to begin at 5:00 p.m. EDT, today. The Webcast may be accessed via a link at https://www.ibm.com/investor/events/earnings-1q22. Presentation charts will be available shortly before the Webcast.

Financial Results Below (certain amounts may not add due to use of rounded numbers; percentages presented are calculated from the underlying whole-dollar amounts).

Contact: IBM
Sarah Meron, 347 891 1770
sarah.meron@ibm.com

Tim Davidson, 914 844 7847
tfdavids@us.ibm.com

INTERNATIONAL BUSINESS MACHINES CORPORATION
COMPARATIVE FINANCIAL RESULTS
(Unaudited; Dollars in millions except per share amounts)
Three Months Ended
March 31,
20222021*
REVENUE
Software$5,772$5,138
Consulting4,8294,262
Infrastructure3,2193,293
Financing154208
Other224284
TOTAL REVENUE14,19713,187
GROSS PROFIT7,3357,027
GROSS PROFIT MARGIN
Software78.8%77.8%
Consulting24.3%27.8%
Infrastructure50.5%56.3%
Financing37.7%35.5%
TOTAL GROSS PROFIT MARGIN51.7%53.3%
EXPENSE AND OTHER INCOME
S,G&A4,5974,688
R,D&E1,6791,616
Intellectual property and custom development income(121)(146)
Other (income) and expense246346
Interest expense311280
TOTAL EXPENSE AND OTHER INCOME6,7126,784
INCOME/(LOSS) FROM CONTINUING OPERATIONS
BEFORE INCOME TAXES623244
Pre-tax margin4.4%1.8%
Provision for/(Benefit from) income taxes(39)(160)
Effective tax rate(6.3)%(65.5)%
INCOME FROM CONTINUING OPERATIONS$662$403
DISCONTINUED OPERATIONS
Income/(Loss) from discontinued operations, net of taxes71552
NET INCOME$733$955
EARNINGS/(LOSS) PER SHARE OF COMMON STOCK
Assuming Dilution
Continuing Operations$0.73$0.45
Discontinued Operations$0.08$0.61
TOTAL$0.81$1.06
Basic
Continuing Operations$0.74$0.45
Discontinued Operations$0.08$0.62
TOTAL$0.82$1.07
WEIGHTED-AVERAGE NUMBER OF COMMON SHARES OUTSTANDING (M's)
Assuming Dilution909.2901.7
Basic899.3893.6
____________________
* Recast to conform with 2022 presentation.

INTERNATIONAL BUSINESS MACHINES CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEET
(Unaudited)
AtAt
March 31, December 31,
(Dollars in Millions)20222021
ASSETS:
Current Assets:
Cash and cash equivalents$9,934$6,650
Restricted cash286307
Marketable securities550600
Notes and accounts receivable - trade, net5,9636,754
Short-term financing receivables, net7,1698,014
Other accounts receivable, net1,0031,002
Inventories1,7761,649
Deferred costs1,1031,097
Prepaid expenses and other current assets3,5483,466
Total Current Assets31,33029,539
Property, plant and equipment, net5,5595,694
Operating right-of-use assets, net3,1083,222
Long-term financing receivables, net4,6105,425
Prepaid pension assets9,9959,850
Deferred costs916924
Deferred taxes7,5677,370
Goodwill56,10655,643
Intangibles, net12,31212,511
Investments and sundry assets1,7711,823
Total Assets$133,275$132,001
LIABILITIES:
Current Liabilities:
Taxes$1,798$2,289
Short-term debt7,6906,787
Accounts payable3,4533,955
Deferred income13,52612,518
Operating lease liabilities954974
Other liabilities6,6357,097
Total Current Liabilities34,05633,619
Long-term debt46,54544,917
Retirement related obligations13,93714,435
Deferred income3,4233,577
Operating lease liabilities2,3582,462
Other liabilities13,84413,996
Total Liabilities114,162113,005
EQUITY:
IBM Stockholders' Equity:
Common stock57,60357,319
Retained earnings153,401154,209
Treasury stock - at cost(169,422)(169,392)
Accumulated other comprehensive income/(loss)(22,532)(23,234)
Total IBM Stockholders' Equity19,05018,901
Noncontrolling interests6295
Total Equity19,11218,996
Total Liabilities and Equity$133,275$132,001

INTERNATIONAL BUSINESS MACHINES CORPORATION
CASH FLOW ANALYSIS
(Unaudited)
Three Months Ended
March 31,
(Dollars in Millions)20222021
Consolidated Net Cash from Operations per GAAP$3,248$4,914
Less: change in IBM Financing receivables1,6312,863
Capital Expenditures, net(378)(529)
Consolidated Free Cash Flow1,2401,522
Acquisitions(698)(1,120)
Divestitures61(15)
Dividends(1,475)(1,457)
Non-Financing Debt4,675(1,725)
Other (includes IBM Financing net receivables and debt)(590)(207)
Change in Cash, Cash Equivalents, Restricted Cash and Short-term Marketable Securities*$3,213$(3,002)
____________________
* Cash flows are presented on a consolidated basis.

INTERNATIONAL BUSINESS MACHINES CORPORATION
CASH FLOW
(Unaudited)
Three Months Ended
March 31,
(Dollars in Millions)20222021
Net Income from Operations$733$955
Depreciation/Amortization of Intangibles1,2571,672
Stock-based Compensation234213
Working Capital / Other(606)(789)
IBM Financing A/R1,6312,863
Net Cash Provided by Operating Activities$3,248$4,914
Capital Expenditures, net of payments & proceeds(378)(529)
Divestitures, net of cash transferred61(15)
Acquisitions, net of cash acquired(698)(1,120)
Marketable Securities / Other Investments, net(344)(335)
Net Cash Provided by/(Used in) Investing Activities$(1,358)$(2,000)
Debt, net of payments & proceeds2,948(4,299)
Dividends(1,475)(1,457)
Financing - Other(95)(26)
Net Cash Provided by/(Used in) Financing Activities$1,377$(5,783)
Effect of Exchange Rate changes on Cash(5)(134)
Net Change in Cash, Cash Equivalents and Restricted Cash*$3,263$(3,002)
____________________
* Cash flows are presented on a consolidated basis.

INTERNATIONAL BUSINESS MACHINES CORPORATION
SEGMENT DATA
(Unaudited)
Three Months Ended March 31, 2022
(Dollars in Millions)SoftwareConsultingInfrastructureFinancing
Revenue$5,772$4,829$3,219$154
Pre-tax Income/(Loss) from Continuing Operations1,13434819984
Pre-tax Margin19.7%7.2%6.2%54.6%
Change YTY Revenue12.3%13.3%(2.3)%(26.2)%
Change YTY Revenue - constant currency15.4%17.4%0.3%(24.5)%
Three Months Ended March 31, 2021*
(Dollars in Millions)SoftwareConsultingInfrastructureFinancing
Revenue$5,138$4,262$3,293$208
Pre-tax Income/(Loss) from Continuing Operations65827729298
Pre-tax Margin12.8%6.5%8.9%47.0%
____________________
* Recast to conform with 2022 presentation.

INTERNATIONAL BUSINESS MACHINES CORPORATION
U.S. GAAP TO OPERATING (Non-GAAP) RESULTS RECONCILIATION
(Unaudited; Dollars in millions except per share amounts)
Three Months Ended March 31, 2022
Continuing Operations
Acquisition-Retirement-TaxKyndryl-
RelatedRelatedReformRelatedOperating
GAAPAdjustments (1)Adjustments (2)ImpactsImpacts (3)(Non-GAAP)
Gross Profit$7,335$181$-$-$-$7,516
Gross Profit Margin51.7%1.3pts. -pts. -pts. -pts.52.9%
S,G&A$4,597$(286)$-$-$(0)$4,311
Other (Income) & Expense246(1)(202)-(222)(179)
Total Expense & Other (Income)6,712(287)(202)-(222)6,001
Pre-tax Income from Continuing
Operations
623468202-2221,515
Pre-tax Income Margin from
Continuing Operations
4.4%3.3pts. 1.4pts. -pts. 1.6pts.10.7%
Provision for/(Benefit from) Income
Taxes (4)
$(39)$109$58$116$-$244
Effective Tax Rate(6.3)%9.1pts. 4.6pts. 7.7pts. 0.9pts.16.1%
Income from Continuing Operations$662$359$144$(116)$222$1,271
Income Margin from Continuing
Operations
4.7%2.5pts. 1.0pts. (0.8)pts. 1.6pts.9.0%
Diluted Earnings/(Loss) Per Share:
Continuing Operations
$0.73$0.39$0.16$(0.13)$0.24$1.40
Three Months Ended March 31, 2021
Continuing Operations
Acquisition-Retirement-TaxKyndryl-
RelatedRelatedReformRelatedOperating
GAAPAdjustments (1)Adjustments (2)ImpactsImpacts (3)(Non-GAAP)
Gross Profit$7,027$174$-$-$-$7,201
Gross Profit Margin53.3%1.3pts. -pts. -pts. -pts.54.6%
S,G&A$4,688$(288)$-$-$-$4,399
Other (Income) & Expense346(1)(332)--13
Total Expense & Other (Income)6,784(289)(332)--6,162
Pre-tax Income/(Loss) from Continuing
Operations
244463332--1,039
Pre-tax Income Margin from
Continuing Operations
1.8%3.5pts. 2.5pts. -pts. -pts.7.9%
Provision for/(Benefit from) Income
Taxes (4)
$(160)$132$33$19$-$25
Effective Tax Rate(65.5)%41.9pts. 24.2pts. 1.8pts. -pts.2.4%
Income from Continuing Operations$403$330$299$(19)$-$1,013
Income Margin from Continuing
Operations
3.1%2.5pts. 2.3pts. (0.1)pts. -pts.7.7%
Diluted Earnings/(Loss) Per Share:
Continuing Operations
$0.45$0.37$0.33$(0.02)$-$1.12
____________________
(1)Includes amortization of purchased intangible assets, in process R&D, transaction costs, applicable restructuring and related expenses, tax charges related to acquisition
integration and pre-closing charges, such as financing costs.
(2)Includes amortization of prior service costs, interest cost, expected return on plan assets, amortized actuarial gains/losses, the impacts of any plan curtailments/
settlements and pension insolvency costs and other costs.
(3)Primarily relates to fair value changes in shares of Kyndryl common stock that were retained by IBM.
(4)Tax impact on operating (non-GAAP) pre-tax income from continuing operations is calculated under the same accounting principles applied to the As Reported pre-tax
income under ASC 740, which employs an annual effective tax rate method to the results.
© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.